Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease: case reports and literature review

@inproceedings{Chandrasekar2008IntravenousIT,
  title={Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease: case reports and literature review},
  author={T. Chandrasekar and Nawazish Naqvi and A Waddington and Rpd Cooke and Hameed Anijeet and CW Gradden and K. A. Abraham and Cf Wong},
  booktitle={NDT plus},
  year={2008}
}
Clostridium difficile toxin (CDT) colitis is the most common cause of infectious diarrhoea in hospitalized patients and is a frequent cause of morbidity and mortality in hospitalized patients. Failure to mount an immune response to CDT appears to be an important mechanism for recurrent diarrhoea [1, 2]. One of the factors associated with an increased risk for recurrence of CDT colitis is advanced chronic kidney disease (CKD) [1]. There is anecdotal evidence of benefit from treatment with… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES